Alpha Cognition Inc. (ACOGF)

Alpha Cognition, Inc. is a clinical stage biopharmaceutical company that develops treatments for underserved neurodegenerative diseases such as Alzheimer's Dementia and Amyotrophic Lateral Sclerosis. The company was founded in 2000 and is headquartered in Vancouver, Canada.

Address

1200-750 W PENDER ST
VANCOUVER, A1 V6C 2T8

Founded

2000

Number of Employees

5

Insider Transactions

Filters

Keyboard Shortcuts: Show (a) | Close (Esc)